Stockscreener 앱 받기
60.12
5.08%
-3.1707
전일 마감가:
$63.29
열려 있는:
$63.64
하루 거래량:
43,433
Relative Volume:
0.63
시가총액:
$424.89M
수익:
-
순이익/손실:
$-4.98M
주가수익비율:
-45.62
EPS:
-1.3177
순현금흐름:
$-3.85M
1주 성능:
+16.66%
1개월 성능:
+23.24%
6개월 성능:
+108.39%
1년 성능:
+5,463%
1일 변동 폭
$58.64
$65.00
1주일 범위
$48.94
$65.00
52주 변동 폭
$1.11
$79.02
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
DRUG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRUG
Bright Minds Biosciences Inc
|
60.32 | 448.64M | 0 | -4.98M | -3.85M | -1.3177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.81 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.68 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
552.20 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
809.14 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.45 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-08 | 개시 | BTIG Research | Buy |
| 2025-05-13 | 개시 | TD Cowen | Buy |
| 2025-05-07 | 개시 | Chardan Capital Markets | Buy |
| 2025-01-23 | 개시 | Piper Sandler | Overweight |
| 2025-01-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-01-10 | 개시 | H.C. Wainwright | Buy |
| 2024-11-26 | 개시 | Robert W. Baird | Outperform |
모두보기
Bright Minds Biosciences Inc 주식(DRUG)의 최신 뉴스
Will Bright Minds Biosciences Inc. outperform the marketJuly 2025 Spike Watch & Free Reliable Trade Execution Plans - newser.com
Exit strategy if you’re trapped in Bright Minds Biosciences Inc.2025 Short Interest & Fast Moving Trade Plans - newser.com
Visualizing Bright Minds Biosciences Inc. stock with heatmaps2025 Top Decliners & Low Risk Growth Stock Ideas - newser.com
Has Bright Minds Biosciences Inc. found a price floorJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com
Insiders Who Sold CA$17m Of Bright Minds Biosciences Made The Right Call - simplywall.st
Published on: 2025-10-10 09:53:23 - newser.com
Risk vs reward if holding onto Bright Minds Biosciences Inc.Analyst Downgrade & Free Long-Term Investment Growth Plans - newser.com
How to use Fibonacci retracement on Bright Minds Biosciences Inc.July 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
What technical models suggest about Bright Minds Biosciences Inc.’s comebackQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com
Regression analysis insights on Bright Minds Biosciences Inc. performanceMarket Performance Summary & AI Powered Market Entry Ideas - newser.com
Published on: 2025-10-09 04:28:20 - newser.com
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives $81.00 Consensus Target Price from Analysts - Defense World
Bright Minds Biosciences (NASDAQ:DRUG) Stock Rating Lowered by Wall Street Zen - Defense World
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Rating of "Buy" from Analysts - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Cut to Sell at Wall Street Zen - MarketBeat
Will Bright Minds Biosciences Inc. stock outperform growth indexesJuly 2025 Pullbacks & Daily Market Momentum Tracking - newser.com
BTIG Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Maintains Target Price $72 - 富途牛牛
Published on: 2025-09-30 11:54:24 - earlytimes.in
What analysts say about Bright Minds Biosciences Inc stockResistance Zone Identification & High Return Investment Plans - earlytimes.in
Is Bright Minds Biosciences Inc a good long term investmentMarket Liquidity Analysis & Explosive Capital Growth Plans - earlytimes.in
What drives Bright Minds Biosciences Inc stock priceAI-Driven Market Analysis & Low Risk Investment Growth - earlytimes.in
Bright Minds Biosciences Inc Stock Analysis and ForecastCandlestick Pattern Analysis & Fast Profit Stock Ideas - Early Times
H.C. Wainwright Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Maintains Target Price $85 - 富途牛牛
Goldman Sachs Group Inc. Takes Position in Bright Minds Biosciences Inc. $DRUG - Defense World
Bright Minds Biosciences (NASDAQ:DRUG) Rating Increased to Hold at Wall Street Zen - MarketBeat
Relative strength of Bright Minds Biosciences Inc. in sector analysisProduct Launch & Stepwise Entry/Exit Trade Alerts - newser.com
Using data filters to optimize entry into Bright Minds Biosciences Inc.July 2025 Gainers & Precise Buy Zone Identification - newser.com
Bright Minds Biosciences (NASDAQ:DRUG) Upgraded by Wall Street Zen to Hold Rating - Defense World
Chart based analysis of Bright Minds Biosciences Inc. trendsEarnings Trend Report & High Accuracy Trade Alerts - newser.com
Portfolio Update: How is Bright Minds Biosciences Inc managing supply chain issues2025 Winners & Losers & Free High Return Stock Watch Alerts - khodrobank.com
How to forecast Bright Minds Biosciences Inc. trends using time seriesOptions Play & Fast Gain Stock Trading Tips - newser.com
What data driven models say about Bright Minds Biosciences Inc.’s futureMarket Performance Report & Verified Short-Term Trading Plans - newser.com
HC Wainwright Reaffirms "Buy" Rating for Bright Minds Biosciences (NASDAQ:DRUG) - MarketBeat
Aug Sectors: What is HIPOs 5 year growth outlookEarnings Performance Report & Technical Pattern Based Signals - khodrobank.com
S P Trends: What is Bright Minds Biosciences Inc. s revenue forecast2025 Biggest Moves & Precise Buy Zone Tips - خودرو بانک
Wall Street Analysts Believe Bright Minds Biosciences Inc. (DRUG) Could Rally 81.29%: Here's is How to Trade - Yahoo Finance
Bright Minds Biosciences Reports Q3 2025 Financial Results - MSN
Growth Report: Is Driven Brands Holdings Inc. undervalued by DCF analysisJuly 2025 Weekly Recap & High Conviction Trade Alerts - خودرو بانک
Bright Minds rebounds after $35M private placement - MSN
Will Bright Minds Biosciences Inc benefit from rate cutsJuly 2025 Final Week & Short-Term High Return Strategies - خودرو بانک
Bright Minds Biosciences Inc (DRUG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Bright Minds Biosciences Inc 주식 (DRUG) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 10% Owner |
Oct 15 '24 |
Buy |
5.53 |
372,591 |
2,061,574 |
825,000 |
| Cormorant Asset Management, LP | 10% Owner |
Oct 16 '24 |
Buy |
23.46 |
50,000 |
1,172,813 |
875,000 |
1.10%
자본화:
|
볼륨(24시간):